Company: LRHC
Filing Date: 2025-02-25
Form Type: PRE 14C
Source: 0001213900-25-016765
Chunk: 1

Company: La Rosa Holdings Corp.
Filing Date: 2025-02-25
Form: PRE 14C
Chunk 1
---
 outstanding voting capital stock of the
Company (the “Majority Stockholder”). This Information Statement shall be considered the notice required under Chapter 78
of the Nevada Revised Statutes (the “NRS”).

<div align='center'>WE ARE NOT ASKING YOU FOR A PROXY AND

YOU ARE REQUESTED NOT TO SEND US A PROXY</div>

The following actions (“Corporate
Actions”) were authorized by written consent of the Majority Stockholder on February 4, 2025:

| 1. | Approval of the issuance of Initial Note(as defined below), Incremental Warrants (as defined below) and                                    
 Incremental Notes (as defined below), Interest Shares (as defined below), Conversion Shares (as defined below), and Incremental Conversion 
 Shares (as defined below) in excess of 19.99% of the Company’s issued and outstanding Common Stock, in each case, to comply with           
 the Nasdaq’s 20% rule (as defined below);                                                                                                  |

| 2. | Approval of the amendment (the “Reverse Stock Split Amendment”) to the Articles of Incorporation                                      
 of the Company to provide for a reverse stock split (the “Reverse Stock Split”) of the Common Stock of the Company, that will         
 be at a ratio ranging from one for two (1:2) to one for one hundred (1:100) (the “Split Ratio Range”), the final determination        
 of which shall be determined by the Board of Directors, and authorization to the Board of Directors to effect the Reverse Stock Split 
 at their discretion;                                                                                                                  |

| 3. | Approval of the Third Amended and Restated 2022 La Rosa Holdings Corp. Agent Incentive Plan; |

| 4. | Approval of the filing of a Certificate of Amendment to the Company’s Articles of Incorporation                                  
 to amend the Company’s authorized number of shares of Common Stock to two billion (2,000,000,000) shares of Common Stock, and to 
 restate Sections 3.01 and 3.02 thereof to reflect such amendment.                                                                |

The Majority Stockholder consents
we have received constitutes the only stockholder approval required under the NRS, Nasdaq Listing Rules 5635(b) and 5635(d) (with respect
to the first Corporate Action listed above), our Articles of Incorporation, and our Bylaws, to approve the Corporate Actions. Our Board
of Directors is not soliciting your consent or your proxy in connection with